Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molecular Templates (MTEM) and Synlogic (SYBX).
Molecular Templates (MTEM)
Cowen & Co. analyst Boris Peaker maintained a Buy rating on Molecular Templates yesterday. The company’s shares closed last Monday at $11.40.
According to TipRanks.com, Peaker is a 2-star analyst with an average return of -0.1% and a 37.8% success rate. Peaker covers the Healthcare sector, focusing on stocks such as Iovance Biotherapeutics, Pacira Pharmaceuticals, and Emergent Biosolutions.
Currently, the analyst consensus on Molecular Templates is a Strong Buy with an average price target of $18.00, representing a 44.0% upside. In a report released yesterday, Oppenheimer also maintained a Buy rating on the stock with a $16.00 price target.
See today’s analyst top recommended stocks >>
Synlogic (SYBX)
In a report released yesterday, Mark Breidenbach from Oppenheimer reiterated a Hold rating on Synlogic. The company’s shares closed last Monday at $1.39, close to its 52-week low of $1.38.
According to TipRanks.com, Breidenbach is a 4-star analyst with an average return of 3.5% and a 36.5% success rate. Breidenbach covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Iovance Biotherapeutics, and Syros Pharmaceuticals.
Currently, the analyst consensus on Synlogic is a Moderate Buy with an average price target of $13.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
